(Q46429559)

22 December 2017

review article

1 reference

title

Gene inhibition using antisense oligodeoxynucleotides (English)

1 reference

22 December 2017

author name string

Wagner RW

series ordinal

1

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

22 December 2017

published in

Nature

1 reference

22 December 2017

volume

372

1 reference

22 December 2017

issue

6504

1 reference

22 December 2017

page(s)

333-335

1 reference

22 December 2017

Current concepts in antisense drug design

cites work

1 reference

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

7 January 2021

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

1 reference

7 January 2021

Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery

1 reference

7 January 2021

Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial

1 reference

7 January 2021

Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides

1 reference

7 January 2021

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain

1 reference

7 January 2021

Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B

1 reference

7 January 2021

Intracerebral administration of antisense oligodeoxynucleotides to GAD65 and GAD67 mRNAs modulate reproductive behavior in the female rat.

1 reference

7 January 2021

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

1 reference

7 January 2021

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides

1 reference

7 January 2021

In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides.

1 reference

7 January 2021

Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo

1 reference

7 January 2021

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

1 reference

7 January 2021

Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model

1 reference

7 January 2021

Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats

1 reference

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

7 January 2021

In Vivo Modulation of N-myc Expression by Continuous Perfusion with an Antisense Oligonucleotide

1 reference

7 January 2021

Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression

1 reference

7 January 2021

Biologic and therapeutic significance of MYB expression in human melanoma

1 reference

7 January 2021

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide

1 reference

7 January 2021

Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury

1 reference

7 January 2021

Specificity of antisense oligonucleotides in vivo

1 reference

7 January 2021

In vitro selection of RNA molecules that bind specific ligands

1 reference

7 January 2021

Selection of single-stranded DNA molecules that bind and inhibit human thrombin

1 reference

7 January 2021

Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides

1 reference

7 January 2021

Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification

1 reference

7 January 2021

Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region

1 reference

7 January 2021

Purine nucleosides and nucleotides stimulate proliferation of a wide range of cell types

1 reference

7 January 2021

Modified deoxyoligonucleotides stable to exonuclease degradation in serum

1 reference

7 January 2021

Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells

1 reference

7 January 2021

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

1 reference

7 January 2021

Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines

1 reference

7 January 2021

BCR-ABL antisense purging in chronic myeloid leukaemia

1 reference

7 January 2021

Inhibition of human immunodeficiency virus type-1 env expression by C-5 propyne oligonucleotides specific for Rev-response element stem-loop V.

1 reference

7 January 2021

Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells

1 reference

7 January 2021

Do antisense approaches to the problem of restenosis make sense?

1 reference

7 January 2021

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

7 January 2021

Identifiers

DOI

10.1038/372333A0

1 reference

22 December 2017

Dimensions Publication ID

1031628023

0 references

Fatcat ID

release_mqyvlhzitjaqhjnle3qfnmpo2u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mqyvlhzitjaqhjnle3qfnmpo2u

24 November 2022

mapped directly with Wikidata item

1 reference

22 December 2017